Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 12/20 | 0.50 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.50 |
| ▸ | AKT1 | P31749 | 1/20 | 0.50 |
| ▸ | INPP5B | P32019 | 2/20 | 0.46 |
| ▸ | SRC | P12931 | 5/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4181314 | 0.87 | INPPL1 (0.60) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL5705481 | 0.74 | INPPL1 (0.43) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL28505708 | 0.72 | INPPL1 (0.41) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL18045507 | 0.71 | INPPL1 (0.75) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL4186925 | 0.70 | INPPL1 (0.71) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL28786310 | 0.69 | INPPL1 (0.61) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL5370752 | 0.69 | INPPL1 (0.50) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL25268769 | 0.69 | INPPL1 (0.48) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL3487751 | 0.69 | INPPL1 (0.48) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL574460 | 0.69 | INPPL1 (0.48) | INPPL1INPP5AAKT1INPP5BSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098589-A1 | Method | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2009-04-16 | — | — | US | disclosed |
| EP-1888771-A2 | METHOD FOR DETERMINING PHYTASE ACTIVITY | DANISCO A/S (DK) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006123254-A2 | METHOD FOR DETERMINING PHYTASE ACTIVITY | DANISCO A/S (DK) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098589-A1 | Method | ALPL, PPA1, ITPA | INPPL1 40/4885INPP5A 15/4885AKT1 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.